天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 84946-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 84946-20-3
Chemical Structure| 84946-20-3
Structure of 84946-20-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 84946-20-3 ]

Related Doc. of [ 84946-20-3 ]

Alternatived Products of [ 84946-20-3 ]
Product Citations

Product Details of [ 84946-20-3 ]

CAS No. :84946-20-3 MDL No. :MFCD00800240
Formula : C14H10ClFN2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :PGXALMVNIRPELS-UHFFFAOYSA-N
M.W : 260.69 Pubchem ID :3020241
Synonyms :
Chemical Name :2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole

Calculated chemistry of [ 84946-20-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.07
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 70.45
TPSA : 17.82 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.67
Log Po/w (XLOGP3) : 4.1
Log Po/w (WLOGP) : 4.3
Log Po/w (MLOGP) : 3.72
Log Po/w (SILICOS-IT) : 3.88
Consensus Log Po/w : 3.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.52
Solubility : 0.0078 mg/ml ; 0.0000299 mol/l
Class : Moderately soluble
Log S (Ali) : -4.18
Solubility : 0.0172 mg/ml ; 0.0000661 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.91
Solubility : 0.000324 mg/ml ; 0.00000124 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 84946-20-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 84946-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 84946-20-3 ]

[ 84946-20-3 ] Synthesis Path-Downstream   1~11

  • 1
  • [ 84946-20-3 ]
  • [ 388575-02-8 ]
  • 2
  • [ 84946-20-3 ]
  • [10-(4-fluoro-benzyl)-3,4-dioxo-3,4-dihydro-10<i>H</i>-benzo[4,5]imidazo[2,1-<i>c</i>][1,2,4]triazin-2-yl]-acetic acid [ No CAS ]
  • 3
  • [ 84946-20-3 ]
  • [ 388575-16-4 ]
  • 5
  • [ 177-11-7 ]
  • [ 84946-20-3 ]
  • 8-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane [ No CAS ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In isoamylic alcohol; for 48h;Heating / reflux; EXAMPLE 4 8-[1-(4-Fluorobenzyl)-1H-benzimidazol-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane (2) A mixture formed by 50 g of 2-chloro-1-(4-fluorobenzyl)benzimidazol, 41 g of 1,4-dioxa-8-azaspiro[4.5]decane and 84 mL of diisopropylethylamine in 350 mL of isoamylic alcohol is heated under reflux for 48 hours. Once the reaction has finished, 175 mL of solvent are distilled and slowly cooled to a temperature of 0-5C so that a white solid precipitates. The precipitate produced is filtered and washed with 75 mL of cold isoamylic alcohol, and is dissolved again in 250 mL of water and 250 mL of ethyl acetate. It is stirred, and the organic phase is isolated by decanting. The product is isolated by removing the solvent under reduced pressure, obtaining 60 g of 8-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane (2).
  • 6
  • [ 5382-16-1 ]
  • [ 84946-20-3 ]
  • 1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-4-hydroxypiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
In isoamylic alcohol; for 12h;Heating / reflux; EXAMPLE 2 1-[1-(4-Fluorobenzyl)-1H-benzimidazol-2-yl]-4-hydroxypiperidine (3) A mixture of 3.9 g of 4-hydroxypiperidine, 5 g of 2-chloro-1-(4-fluorobenzyl)-benzimidazol in 30 mL of isoamylic alcohol is taken to reflux for 12 hours. Once the reaction has finished, the product is isolated by removal of the solvent under reduced pressure and redissolving the residue in 15 mL of ethyl acetate and 15 mL of water. The organic phase is decanted, and the aqueous phase is extracted again with 7 mL of ethyl acetate. The organic phases are brought together and the solvent is removed. The obtained residue is crystallized in toluene, obtaining 3.7 g of 1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-4-hydroxypiperidine (3). 13C-NMR (CDCl3, δ in ppm): 34.17 (CH2), 47.05 (CH2), 48.64 (CH2), 67.04 (CH), 109.27 (CH), 143.40 (C), 163.37 (C).
  • 7
  • [ 387827-27-2 ]
  • [ 84946-20-3 ]
  • N-[3-(1-{3-[1-(4-fluorobenzyl)-1H-benzimidazol-2-ylamino]propyl}piperidin-4-yl)phenyl]acetamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
In ethanol; at 150℃; for 2h;Microwave; Example 4; A/-[3-(1-{3-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-ylamino]-propyl}-piperidin-4-yl)-phenyl]-acetamide; 2-Chloro-1-(4-fluoro-benzyl)-1H-benzoimidazole (58 mg, 0.22 mmol) and A/-{3-[1-(3-Amino-propyl)-piperidin-4-yl]-phenyl}-acetamide (Example 1 Step 2, 90 mg, 0.33mmol) were mixed in ethanol (1 ml) and heated in the micro wave at 150 C for 2h.The reaction was extracted with dichloromethane and Na2CO3(aq) and the combinedorganic phases was dried over Na2SO4, filtered, and evaporated giving the crudeproduct which was purified by chromatography (silica,dichloromethane/methanol/ammoniac, 9:1:1%) giving the title compound Example 4.1H-NMR (300 MHz, CDCI3); 8 7.5.1 (d, 1H), 7.38 (s, 1H), 7.10-7.31 (m, 6H), 6.92-7.02(m, 4H), 6.79 (d, 1H), 6.61 (br s, 1H), 5.17 (s, 2H), 3.71 (t, 2H), 3.14 (d, 2H), 2.62 (t,2H), 2.48-2.61 (m, 1H), 2.21 (s, 3H) 2.06-2.15 (m, 2H), 1.91-2.00 (m, 2H), 1.65-1.86(m, 4H).LCMS: Rt 3.48 min, m/z 499.6 [M+].
  • 8
  • (+/-)-cis-1-(3,5-dimethylbenzoyl)-2-(phenylmethyl)-4-piperidinol [ No CAS ]
  • [ 84946-20-3 ]
  • (+/-)-cis-1-(3,5-dimethylbenzoyl)-4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]oxy]-2-(phenylmethyl)piperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
2.85 g (65%) In water; N,N-dimethyl-formamide; EXAMPLE B8 (+-)-cis-1-(3,5-dimethylbenzoyl)-2-(phenylmethyl)-4-piperidinol (2.6 g) dissolved in N,N-dimethylformamide (100 ml) was stirred under N2. Sodium hydride (60%) (0.36 g) was added and the mixture was stirred at 40 C. for 1 hour. <strong>[84946-20-3]2-Chloro-1-[(4-fluorophenyl)-methyl]-1H-benzimidazole</strong> (2.6 g) was added and the mixture was stirred at 60 C. for 20 hours. The solvent was evaporated and the residue was taken up in water and CH2 Cl2. The organic layer was separated, dried, filtered and the solvent evaporated. The residue was purified by column chromatography over silica gel (eluent: CH2 Cl2 /CH3 OH 97/3). The pure fractions were collected and the solvent was evaporated. The residue was crystallized from DIPE, yielding 2.85 g (65%) of (+-)-cis-1-(3,5-dimethylbenzoyl)-4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]oxy]-2-(phenylmethyl)piperidine (comp. 70; mp. 154.1 C.).
  • 9
  • [ 84946-20-3 ]
  • [ 75970-99-9 ]
YieldReaction ConditionsOperation in experiment
With 1-methyl-pyrrolidin-2-one; sodium hydroxide; In tetrahydrofuran; EXAMPLE 42 To a 25 mL 3-neck flask equipped with a thermometer, reflux consenser and stir bar were added, under a nitrogen atmosphere, 885.6 mg (4.8 mmol) of Compound XXII, obtained according to the procedure of Example 41, and 0.93 mL (8.0 mmol) of lutidine. The mixture was heated to 120 C., whereupon a solution of 1.04 g (4 mmol., 1 eq.) of Compound X (Aldrich Chemical Co., Milwaukee, Wis.), 8 mmol of tetrabutylammonium fluoride (obtained from its 1.0M THF solution by distillation under vacuum with anhydrous toluene) and 4 mL of N-methylpyrrolidinone was added slowly over 2 h. The reaction mixture was allowed to stir at 120 C. for 1 h. High-performance liquid chromatography revealed >95% coversion to Compound XXIII. The reaction mixture was allowed to cool to ambient temperature, and slowly poured into a solution of 5% aqueous NaOH while stirring. The resulting suspension was allowed to stir at 0-10 C. for 30 minutes, and the resulting solid product was collected by vacuum filtration, washed with water (3*5 mL), and air dried for 30 minutes under vacuum to afford crude Compound XXIII: 1 H NMR (300 MHz, CDCl3) δ7.52 (1H, d, J=7.8 Hz), 7.20-7.00 (7H, m, two groups), 5.13 (2H, s), 4.40 (1H, NH br. d), 4.32 (2H, pseudo d), 4.20 (1H, m), 3.00 (2H, pseudo t), 2.15 (2H, pseudo d), 1.30 (2H, m overlapped), 1.26 (9H, s); 13 C NMR (75 MHz, CDCl3) δ176.3, 164.2 and 161.0 (13 C-19 F coupling), 153.3, 142.4, 134.6, 131.4, 128.4, 121.7, 120.0, 116.6, 116.4, 116.1, 107.5, 50.5, 45.1, 44.2, 38.9, 33.1, 28.6. It is to be noted that under the same reaction conditions as above, but without the use of tetrabutylammonium fluoride, only 3.5% conversion (high-performance liquid chromatography) to Compound XXIII was achieved after 3 h at 120 C. The Compound XXIII obtained above was placed in a 50 mL, 3-neck flask equipped with a thermometer, reflux condenser and stir bar. 5 mL of 48% hydrobromic acid was added, and the resulting mixture was heated to 110 C. and allowed to stir at that temperature for 2 h. After the reaction was complete (>98% conversion to norastemizole as shown by high-performance liquid chromatography), the reaction mixture was allowed to cool to room temperature, and 10 mL of toluene and 10 mL of water were added, with stirring.
With 1-methyl-pyrrolidin-2-one; sodium hydroxide; In tetrahydrofuran; EXAMPLE 43 Norastemizole. To a 25 mL 3-neck flask equipped with a thermometer, ref lux consenser and stir bar were added, under a nitrogen atmosphere, 822 mg (4.8 mmol) of Compound XVI, obtained according to the procedure of Example 6, and 0.93 mL (8.0 mmol) of lutidine. The mixture was heated to 120 C., whereupon a solution of 1.04 g (4 mmol., 1 eq.) of Compound X (Aldrich Chemical Co., Milwaukee, Wis.), 8 mmol of tetrabutylammonium fluoride (obtained from its 1.0M THF solution by distillation under vacuum with anhydrous toluene) and 4 mL of N-methylpyrrolidinone was added slowly over 2 h. The reaction mixture was allowed to stir at 120 C. for 2 h. High-performance liquid chromatography revealed >95% coversion to Compound XVIII. The reaction mixture was allowed to cool to ambient temperature, and slowly poured into a solution of 5% aqueous NaOH while stirring. The resulting suspension was allowed to stir at 0-10 C. for 30 minutes, and the resulting solid product was collected by vacuum filtration, washed with water (3*5 mL), and air dried for 30 minutes under vacuum to afford a crude mixture of Compound XVIII and 6% (HPLC) of migration product Compound XIX. NMR data for Compound XVIII: 1 H NMR (300 MHz, DMSO-d6) δ7.30-7.02 (6H, m two groups), 6.95 (1H, pseudo t, J=7.8, 2.3 Hz), 6.85 (1H, pseudo t, J=7.8, 2.3 Hz), 5.35 (2H, s), 4.33 (1H, pseudo d), 4.02 (1H, m), 3.83 (1H, pseudo d), 3.17 (1H, pseudo t), 2.75 (1H, pseudo t), 2.02 (3H, s), 2.0 (2H, m overlapped), 1.45 (2H, m); 13 C NMR (75 MHz, DMSO-d6) δ168.0, 163.0 and 159.7 (13 C-19 F coupling), 153.9, 142.8, 134.3, 133.5, 129.1, 129.0, 128.2, 120.5, 118.4, 115.5, 115.2, 107.9, 44.8, 43.7, 32.3, 31.5, 21.4. It is to be noted that under the same reaction conditions as above, but without the use of tetrabutylammonium fluoride, only 4.9% conversion (high-performance liquid chromatography) to Compound XVIII was achieved after 3 h at 120 C. In addition, without the use of tetrabutylammonium fluoride, the ratio of Compound XVIII:Compound XIX was 4:1. The mixture of Compound XVIII obtained above was placed in a 50 mL, 3-neck flask equipped with a thermometer, reflux condenser and stir bar. 5 mL of 6N hydrochloric were added, and the resulting mixture was heated to 110 C. and allowed to stir at that temperature for 5 h. After the reaction was complete (>98% conversion to norastemizole as shown by high-performance liquid chromatography), the reaction mixture was allowed to cool to room temperature, and 10 mL of toluene and 10 mL of water were added, with stirring.
  • 10
  • [ 58859-46-4 ]
  • [ 84946-20-3 ]
  • [ 75970-99-9 ]
YieldReaction ConditionsOperation in experiment
With 2,3-Lutidine; 1-methyl-pyrrolidin-2-one; sodium hydroxide; In tetrahydrofuran; EXAMPLE 8a To a 25 mL 3-neck flask equipped with a thermometer, reflux consenser and stir bar were added, under a nitrogen atmosphere, 822 mg (4.8 mmol) of Compound XII (Lancaster Synthesis, Inc., Windham, N.H.), and 0.93 mL of lutidine. The mixture was heated to 120 C., whereupon a solution of 1.04 g (4 mmol., 1 eq.) of Compound X (Aldrich Chemical Co., Milwaukee, Wis.), 8 mmol of tetrabutylammonium fluoride (obtained from its 1.0M THF solution by distillation under vacuum with anhydrous toluene) and 4 mL of N-methylpyrrolidinone was added slowly over 2 h. The reaction mixture was allowed to stir at 120 C. for 1 h. High-performance liquid chromatography revealed >95% coversion to Compound XIVa (in free base form). The reaction mixture was allowed to cool to ambient temperature, and slowly poured into a solution of 5% aqueous NaOH while stirring. The resulting suspension was allowed to stir at 0-10 C. for 30 minutes, and the resulting solid product was collected by vacuum filtration, washed with water (3*5 mL), and air dried for 30 minutes under vacuum to afford crude Compound XIVa (in free base form): 1 H NMR (300 MHz, CDCl3) δ7.53 (1H, d, J=7.8 Hz), 7.22-6.92 (7H, m, two groups), 5.12 (2H, s), 4.37 (1H, NH br. d), 4.12 (2H+1H, m overlapped), 4.07 (2H, q, J=7.0 Hz), 2.98 (2H, pseudo t), 2.09 (2H, pseudo d), 1.30 (2H, m overlapped), 1.24 (3H, t, J=7.0 Hz); 13 C NMR (75 MHz, CDCl3) δ164.2 and 161.0 (13 C-19 F coupling), 155.6, 153.3, 142.2, 134.5, 131.4, 128.3, 121.8, 120.0, 116.6, 116.3, 116.1, 107.5, 61.5, 50.1, 45.0, 42.8, 32.6, 14.8. It is to be noted that under the same reaction conditions as above, but without the use of tetrabutylammonium fluoride, only 5% conversion (high-performance liquid chromatography) to Compound XIVa (in free base form) was achieved after 3 h at 120 C. The crude Compound XIVa (in free base form) obtained above was placed in a 50 mL, 3-neck flask equipped with a thermometer, reflux condenser and stir bar. 5 mL of 48% hydrobromic acid was added, and the resulting mixture was heated to 110 C. and allowed to stir at that temperature for 2 h. After the reaction was complete (>98% conversion to norastemizole as shown by high-performance liquid chromatography), the reaction mixture was allowed to cool to room temperature, and 10 mL of toluene and 10 mL of water were added, with stirring.
  • 11
  • [ 84946-20-3 ]
  • 1-[(4-fluorophenyl)methyl]-1H-benzimidazole-2-thiol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With thiourea; In ethanol; di-isopropyl ether; EXAMPLE 9 A mixture of 8.35 parts of thiourea, 26 parts of 2-chloro-1-[(4-fluorophenyl)methyl]-1H-benzimidazole and 400 parts of ethanol was stirred and refluxed for 5 hours. The reaction mixture was evaporated. The residue was suspended in 2,2'-oxybispropane. The precipitated product was filtered off and crystallized from ethanol, yielding 6.1 parts of 1-[(4-fluorophenyl)methyl]-1H-benzimidazole-2-thiol; mp. 194.7 C. (62).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 84946-20-3 ]

Fluorinated Building Blocks

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 1977-72-6

[ 1977-72-6 ]

5-Fluoro-1H-benzo[d]imidazole

Similarity: 0.71

Chemical Structure| 769158-12-5

[ 769158-12-5 ]

2-Chloro-6-fluoroquinazolin-4(3H)-one

Similarity: 0.66

Chemical Structure| 86604-86-6

[ 86604-86-6 ]

2-Chloro-6-(trifluoromethyl)benzimidazole

Similarity: 0.64

Aryls

Chemical Structure| 2622-63-1

[ 2622-63-1 ]

1-Methyl-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.64

Chemical Structure| 85979-59-5

[ 85979-59-5 ]

2-Chloro-4-(4-fluoro-phenyl)-pyrimidine

Similarity: 0.63

Chemical Structure| 2622-60-8

[ 2622-60-8 ]

1-Phenyl-1H-benzoimidazole

Similarity: 0.62

Chemical Structure| 621-72-7

[ 621-72-7 ]

2-Benzyl-1H-benzo[d]imidazole

Similarity: 0.60

Chemical Structure| 2963-77-1

[ 2963-77-1 ]

4-(1H-Benzo[d]imidazol-2-yl)aniline

Similarity: 0.60

Chlorides

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 15965-57-8

[ 15965-57-8 ]

2-Chloro-7-methyl-1H-benzo[d]imidazole

Similarity: 0.73

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.67

Chemical Structure| 1609452-31-4

[ 1609452-31-4 ]

7,8-Dibromo-2-chloro-9-methyl-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline

Similarity: 0.66

Related Parent Nucleus of
[ 84946-20-3 ]

Benzimidazoles

Chemical Structure| 108662-49-3

[ 108662-49-3 ]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 256519-11-6

[ 256519-11-6 ]

2-Chloro-7-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 15965-57-8

[ 15965-57-8 ]

2-Chloro-7-methyl-1H-benzo[d]imidazole

Similarity: 0.73

Chemical Structure| 1977-72-6

[ 1977-72-6 ]

5-Fluoro-1H-benzo[d]imidazole

Similarity: 0.71

Chemical Structure| 4857-06-1

[ 4857-06-1 ]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.67

; ;